Short report: Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 5, 2009, Pages 718-722

  Finney, Constance A M ^a,b,c,e   Lu, Ziyue ^a,b,c,e   Lebourhis, Lionel ^a,b,c   Philpott, Dana J ^a,b,c   Kain, Kevin C ^a,b,c,d  

^a Division of Infectious Diseases   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

^e Department of Molecular Genetics McLaughlin Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CYTOPLASM PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; CARD15 PROTEIN, MOUSE; CARD4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CONTROLLED STUDY; HOST; IMMUNE RESPONSE; INFECTION; INFLAMMATION; MOUSE; NONHUMAN; PARASITEMIA; PATHOGENESIS; PLASMODIUM BERGHEI; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; IMMUNOLOGY; MALARIA; METABOLISM; MORTALITY; MOUSE MUTANT;

ANIMALIA; MURINAE; MUS; PLASMODIUM BERGHEI;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; PARASITEMIA; PLASMODIUM BERGHEI;

EID: 66149113283     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.718     Document Type: Article

References (53)

1. World Health Organization, Communicable Diseases Cluster, 2000. Severe falciparum malaria. Trans R Soc Trap Med Hyg 94 (Suppl 1): S1-S90.
2. Lou J, Lucas R, Grau GE, 2001. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev 14: 810-820.
3. de Souza JB, Riley EM, 2002. Cerebral malaria: the contribution of studies in animal models to our understanding of immunop-athogenesis. Microbes Infect 4: 291-300.
4. Rest JR, 1982. Cerebral malaria in inbred mice. I. A. new model and its pathology. Trans R Soc Trop Med Hyg 76: 410-415.
5. de Kossodo S, Grau GE, 1993. Role of cytokines and adhesion molecules in malaria immunopathology. Stem Cells 11: 41-48.
6. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P, 1987. Tumor necrosis factor (cachectin) as an essential media-tor in murine cerebral malaria. Science 237: 1210-1212.
7. Grau GE, Piguet PF, Vassalli P, Lambert PH, 1989. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev 112: 49-70.
8. Lucas R, Lou JN, Juillard P, Moore M, Bluethmann H, Grau GE, 1997. Respective role of TNF receptors in the development of experimental cerebral malaria. J Neuroimmunol 72: 143-148.
9. Piguet PF, Kan CD, Vesin C, 2002. Role of the tumor necrosis fac-tor receptor 2 (TNFR2) in cerebral malaria in mice. Lab Invest 82:1155-1166.
10. Gowda DC, 2007. TLR-mediated cell signaling by malaria GPIs. Trends Parasitol 23: 596-604.
11. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12 (p70) in Malian children with severe Plasmodium falci-parum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72: 5630-5637.
12. Malaguarnera L, Musumeci S, 2002. The immune response to Plasmodium falciparum malaria. Lancet Infect Dis 2: 472-478.
13. Riley EM, Wahl S, Perkins DJ, Schofield L, 2006. Regulating immunity to malaria. Parasite Immunol 28: 35-49.
14. Stevenson MM, Riley EM, 2004. Innate immunity to malaria. Nat Rev Immunol 4:169-180.
15. Aderem A, 2003. Phagocytosis and the inflammatory response. J Infect Dis 187 (Suppl 2): S340-S345.
16. Akira S, Uematsu S, Takeuchi O, 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
17. Herskovits A A, Auerbuch V, Portnoy DA, 2007. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 3: e51.
18. Medzhitov R, Janeway C Jr, 2000. Innate immune recognition: mechanisms and pathways. Immunol Rev 173: 89-97.
19. Stuart LM, Ezekowitz RA, 2005. Phagocytosis: elegant complexity. Immunity 22: 539-550.
20. Chamaillard M, Girardin SE, Viala J, Philpott DJ, 2003. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5: 581-592.
21. Inohara, Chamaillard, McDonald C, Nuñez G, 2005. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 74: 355-383.
22. Medzhitov R, 2001. Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-145.
23. Le Bourhis L, Benko S, Girardin SE, 2007. Nodi and Nod2 in innate immunity and human inflammatory disorders. Biochem Soc Trans 35:1479-1484.
24. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE, 2006. Nod-like proteins in immunity, inflammation and disease. Nat Immunol 7:1250-1257.
25. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, Yamamoto M, Takeuchi O, Itagaki S, Kumar N, Horii T, Akira S, 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 201:19-25.
26. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, Akira S, Woods AS, Gowda DC, 2005. Induction of proinflam-matory responses in macrophages by the glycosylphosphati-dylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280:8606-8616.
27. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, Visintin A, Halmen KA, Lamphier M, Olivier M, Bartholomeu DC, Gazzinelli RT, Golenbock DT, 2007. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci USA 104:1919-1924.
28. Coban C, Ishii KJ, Uematsu S, Arisue N, Sato S, Yamamoto M, Kawai T, Takeuchi O, Hisaeda H, Horii T, Akira S, 2007. Pathological role of Toll-like receptor signaling in cerebral malaria. Int Immunol 19: 67-79.
29. Griffith JW, O'Connor C, Bernard K, Town T, Goldstein DR, Bucala R, 2007. Toll-like receptor modulation of murine cere-bral malaria is dependent on the genetic background of the host. J Infect Dis 196:1553-1564.
30. Lepenies B, Cramer JP, Burchard GD, Wagner H, Kirschning CJ, Jacobs T, 2007. Induction of experimental cerebral malaria is independent of TLR2/4/9. Med Microbiol Immunol 179: 39-44.
31. Togbe D, Schofield L, Grau GE, Schnyder B, Boissay V, Charron S, Rose S, Beutler B, Quesniaux VF, Ryffel B, 2007. Murine cere-bral malaria development is independent of Toll-like receptor signaling. Am J Pathol 170:1640-1648.
32. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV
33. A Mai functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523-528.
34. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR, Otchwemah RN, Dietz E, Ehrhardt S, Schroder NW, Bienzle U, Schumann RR, 2006. Toll-like receptor (TLR) poly-morphisms in African children: common TLR-4 variants predis-pose to severe malaria. Proc Natl Acad Sci USA 103:177-182.
35. Carneiro LA, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH, 2008. Nod-like proteins in inflammation and disease. J Pathol 214:136-148.
36. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ, 2003. Nodi detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587.
37. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ, 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872.
38. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, Nunez G, Flavell RA, 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731-734.
39. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AR Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Ferrero RL, 2004. Nodi responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 5:1166-1174.
40. Ockenhouse CF, Hu WC, Kester KE, Cummings JF, Stewart A, Heppner DG, Jedlicka AE, Scott AL, Wolfe ND, Vahey M, Burke DS, 2006. Common and divergent immune response sig-naling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun 74: 5561-5573.
41. John CC, Panoskaltsis-Mortari A, Opoka RO, Park GS, Orchard PJ, Jurek AM, Idro R, Byarugaba J, Boivin MJ, 2008. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg 78:198-205.
42. John CC, Park GS, Sam-Agudu N, Opoka RO, Boivin MJ, 2008. Elevated serum levels of IL-lra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine 41:204-208.
43. Ouma C, Davenport GC, Awandare GA, Keller CC. Were T, Otieno MF, Vulule JM, Martinson J, Ong'echa JM, Ferrell RE, Perkins DJ, 2008. Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malar-ial anemia and functional changes in IL-1beta production. J Infect Dis 198:1219-1226.
44. Raices RM, Kannan Y, Sarkar A, Bellamkonda-Athmaram V, Wewers MD, 2008. A synergistic role for IL-1beta and TNFalpha in monocyte-derived IFNgamma inducing activity. Cytokine 44:234-241.
45. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC, 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria..1 Immunol 157:1620-1624.
46. Amani V, Vigario AM, Belnoue E, Marussig M, Fonseca L, Mazier D, Renia L, 2000. Involvement of IFN-gamma receptor-medi-cated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol 30: 1646-1655.
47. Lovegrove FE, Gharib SA, Patel SN, Hawkes CA, Kain KC, Liles WC, 2007. Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in suscepti-bility to experimental cerebral malaria. Am J Pathol 171: 1894-1903.
48. Pedra JH, Sutterwala FS, Sukumaran B, Ogura Y, Qian F, Montgomery RR, Flavell RA, Fikrig E, 2007. ASC/PYCARD and caspase-1 regulate the IL-18/IFN-gamma axis during Anaplasma phagocytophilum infection. J Immunol 179: 4783-4791.
49. Mitchell AJ, Hansen AM, Hee L, Ball HJ, Potter SM, Walker JC, Hunt NH, 2005. Early cytokine production is associated with protection from murine cerebral malaria. Infect lmmun 73: 5645-5653.
50. Ferwerda G, Girardin SE, Kullberg BJ, Le Bourhis L, de Jong DJ, Langenberg DM, van Crevel R, Adema GJ, Ottenhoff TH, Van der Meer JW, Netea MG, 2005. NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium tuber-culosis. PLoS Pathog 1: 279-285.
51. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S, 2003. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124: 1001-1009.
52. Takahashi Y, Isuzugawa K, Murase Y, Imai M, Yamamoto S, Iizuka M, Akira S, Bahr GM, Momotani E, Hori M, Ozaki H, Imakawa K, 2006. Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J Vet Med Sci 68:471-478.
53. Hanum PS, Hayano M, Kojima S, 2003. Cytokine and chemokine responses in a cerebral malaria-susceptible or-resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol 15: 633-640.